Rhumbline Advisers Bristol Myers Squibb CO Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rhumbline Advisers holds 3,685,409 shares of BMY stock, worth $213 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,685,409

Previous 3,820,181 3.53%

Holding current value

$213 Million

Previous $159 Million 20.21%

% of portfolio

0.18%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $5.35 Million - $6.97 Million	-134,772 Reduced 3.53%	3,685,409 $191 Million
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $1.89 Million - $2.48 Million	46,882 Added 1.24%	3,820,181 $159 Million
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $77,199 - $87,529	1,609 Added 0.04%	3,773,299 $205 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $8.35 Million - $9.96 Million	-172,245 Reduced 4.37%	3,771,690 $194 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $1.77 Million - $1.97 Million	-30,510 Reduced 0.77%	3,943,935 $229 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $3.41 Million - $3.78 Million	53,481 Added 1.36%	3,974,445 $254 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $3.14 Million - $3.56 Million	47,826 Added 1.23%	3,920,964 $272 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $11.4 Million - $13.5 Million	165,927 Added 4.48%	3,873,138 $279 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $12,370 - $7.31 Million	95,154 Added 2.63%	3,707,211 $264 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $6.45 Million - $7.1 Million	88,790 Added 2.52%	3,612,057 $278 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $2.18 Million - $2.61 Million	-35,397 Reduced 0.99%	3,523,267 $257 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $2.61 Million - $3.05 Million	48,746 Added 1.39%	3,558,664 $222 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $8.26 Million - $9.68 Million	-139,632 Reduced 3.83%	3,509,918 $208 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $13.8 Million - $15 Million	-223,034 Reduced 5.76%	3,649,550 $244 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $8.99 Million - $10.1 Million	-151,460 Reduced 3.76%	3,872,584 $244 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $1.29 Million - $1.46 Million	-22,305 Reduced 0.55%	4,024,044 $250 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $546,331 - $605,407	-9,513 Reduced 0.23%	4,046,349 $244 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $4.77 Million - $5.58 Million	87,029 Added 2.19%	4,055,862 $238 Million
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $386,280 - $561,354	8,325 Added 0.21%	3,968,833 $221 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $58.4 Million - $76.2 Million	1,186,702 Added 42.78%	3,960,508 $254 Million
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $2.65 Million - $3.15 Million	62,074 Added 2.29%	2,773,806 $141 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $853,848 - $944,170	19,136 Added 0.71%	2,711,732 $123 Million
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $2.27 Million - $2.71 Million	50,323 Added 1.9%	2,692,596 $128 Million
Q4 2018 Jan 31, 2019	BUY	$48.76 - $63.23 $447,177 - $579,882	9,171 Added 0.35%	2,642,273 $137 Million
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $2.3 Million - $2.59 Million	-41,621 Reduced 1.56%	2,633,102 $163 Million
Q2 2018 Aug 06, 2018	BUY	$50.53 - $62.98 $987,002 - $1.23 Million	19,533 Added 0.74%	2,674,723 $148 Million
Q1 2018 May 02, 2018	SELL	$59.92 - $68.98 $1.88 Million - $2.16 Million	-31,381 Reduced 1.17%	2,655,190 $168 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $4.1 Million - $4.47 Million	68,390 Added 2.61%	2,686,571 $165 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $145 Million - $167 Million	2,618,181	2,618,181 $167 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Bristol Myers Squibb CO Transaction History